Stuart Dutton promoted to CFO to realise ambitious growth targets

We are delighted to announce Stuart Dutton as Everything Genetic’s new Chief Financial Officer (CFO).

Stuart, who joined the team from a corporate finance background with Sedulo, will apply his track record of growing and transforming tech and retail SMEs for the business.

With a background as a qualified Chartered Accountant, Stuart’s former role saw him lead a high growth team, navigating businesses through sales, mergers, acquisitions, and equity fundraisers, which ultimately led him to becoming a non-exec director for several firms.

Stuart joined Everything Genetic as Finance Director in October 2021. However, after a successful start including helping to secure a £5m funding boost for the business from Tradeplus24, he has recently been promoted to CFO, with a remit of driving forward the company’s expansion in the life sciences sector.

Commenting on his new role, Stuart said: “I’m delighted to have been promoted to CFO at Everything Genetic, helping the business to work towards delivering on its ambitious growth plans.

“In my former roles, I worked closely with several businesses across a variety of sectors, but I really wanted to become fully immersed within a business which has strong growth potential.

“2021 was a very successful year for Everything Genetic, which saw us hit £35 million turnover. That enabled us to skip funding rounds and re-invest heavily into the business to realise the vision of democratising testing.

“Last month’s £5m financing deal was a great initial win for the business, to further realise its potential. I’m excited to see where we can go next in further building and diversifying our cancer and wellness offering, in addition to attracting new investors.”

Our CEO, James Price, said: “Stuart’s background as an accountant, his growth mindset and familiarity with fundraising processes made him a perfect fit for us at Everything Genetic.

“We’re now in a position where we can emerge from the pandemic to re-invest into the cancer and wellness sectors – addressing how the country can better utilise genetic testing to overcome some of the UK’s most pressing healthcare problems.

“Whether building further on the companies we’ve invested in, our newly expanded facilities, or our recent supplier deal with Tesco, suffice to say, we’ve had an exciting year so far and I can’t wait to see where Stuart can help us go to next.”